Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that genetic changes in the glucocorticoid receptor can lead to conditions affecting stress response, immunity, and metabolism, requiring personalized treatment.

A man developed autoimmune issues after a transplant, improved with treatment, but died from leukemia relapse.

A man with both skin lesions and lung cancer improved quickly with chemotherapy, suggesting the skin condition might be a reaction to immune system injury.

A 16-year-old boy with Castleman's disease and lupus was successfully treated and showed no recurrence.

Digital gangrene can be an unusual first sign of late-onset lupus.

The woman was diagnosed with systemic lupus erythematosus (SLE) after initial misdiagnosis and improved with proper treatment.

Mycophenolate mofetil is safer and more effective than cyclophosphamide for treating lupus nephritis.

A kidney transplant patient developed leprosy, likely due to immunosuppression and genetic factors, and improved with treatment.

Sulfasalazine can cause severe allergic reactions leading to long-term autoimmune issues like hair loss and skin discoloration.

Benign follicular mucinosis involves immune cells attacking hair follicles.

A rare type of skin cancer with mucosal involvement was partially treated but eventually relapsed.

A man had bad reactions to a hair loss treatment called DNCB.

Some patients with severe alopecia areata developed skin darkening from their treatment, which may indicate a less effective response to the therapy.

Total glucosides of paeony may help treat alopecia areata by reducing inflammation and hair loss.

CD8+ T cells attack hair follicle stem cells, causing scarring and hair loss.

Current corticosteroid pulse therapy is not very effective for severe rapidly progressive alopecia areata.

Targeting MIG and MCP-1 may help treat inflammation in alopecia areata.

Rituximab may cause skin issues, but baricitinib can help improve them.

Anti-SRP myopathy can be linked to systemic lupus erythematosus and may improve with specific treatment.

Higher CRHR1 levels in AA patients lead to increased inflammation.

Anti-MND antibodies are present in various diseases, not just PBC, and their levels don't correlate with disease activity or skin symptoms.

A woman with dermatomyositis improved after treatment for neck panniculitis, suggesting similar treatment for related conditions.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

cGVHD often severely affects the skin, causing rapid aging and other issues.

A kidney transplant patient developed pink skin bumps with spiny centers on her face and limbs.

Bortezomib chemotherapy can cause temporary skin rashes.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

Mice with human fetal thymic tissue and stem cells developed symptoms similar to chronic graft-versus-host disease.

Terbinafine effectively treated kerion celsi despite disrupted immune responses.

A woman with Lupus Vasculitis improved after treatment with steroids and other medications.